Intrinsic Functional Connectivities of “Where” Visual Network in Patients with Mild Cognitive Impairment
Yanjia Deng1, Lin Shi2,3, Defeng Wang1,4,5, and ADNI Alzheimer’s Disease Neuroimaging Initiative6

1Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 3Chow Yuk Ho Technology Centre for Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 4Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China, People's Republic of, 5Research Center for Medical Image Computing, Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 6Los Angeles, CA, United States

Synopsis

In order to extend the knowledge on the impaired pattern of “where” visual perception in mild cognitive impairment (MCI) patients, we investigated the connectivity of the “where” visual networks in terms of intrinsic interaction in early and late MCI patients. Resting-state functional MRI data of late MCI, early MCI and matched healthy controls from Alzheimer’s Disease Neuroimaging Initiative dataset were analyzed to investigate the alterations of interregional connections of “where” visual networks. Significant increased interregional connectivties in late MCI patients were found, which may extend the current knowledge on the pattern of visual perceptual impairment in MCI patients.

Purpose

Altered regional activation of cortices related to “where” vision, including the motion and spatial visual perception, previously has been identified in Alzheimer’s disease (AD)/mild cognitive impairment (MCI) patients. More importantly, several studies have demonstrated1, 2 that the decline of “where” visual function may contribute to the intellectual deterioration in AD. Thus, better understanding of “where” visual dysfunction would be helpful for diagnosis of AD and interpretation of cognitive evaluations3. Therefore, in this study, in order to extend the knowledge on the impaired pattern of “where” visual perception in MCI patients, we aim to further investigate the connectivity of the “where” visual networks in terms of intrinsic interaction in early and late MCI patients.

Methods

To achieve the above aim, the study was carried out in two steps. First step, the activation likelihood estimation (ALE) analysis, a coordinate-base meta-analysis approach, was performed to locate the cortices of “where” visions. The coordinates of “where” visual cortices were obtained from the results of ALE analysis, and then were applied in second step to define the cortical regions of interest (ROIs) of HLV cortices. In the second step, the resting-state functional MRI (rs-fMRI) data of 131 subjects (including 52 early MCI (EMCI), 35 late MCI (LMCI) and 44 normal control (CN)) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu) were analyzed to investigate the alternations of “where” visual network. The resting-state functional connectivity (RSFC) between each pair of ROIs calculated as the correlation between the rs-fMRI time courses of the two ROIs was compared among the three groups.

Results

Cortices and ROIs of “where” vision

Totally, 22 significant clusters were found, which were mainly located in the bilateral occipital complex, superior parietal lobule, postcentral gyrus, inferior frontal gyrus and fusiform gyrus (Figure1). Based on the coordinates and BA regions of these clusters, 25 spherical ROIs were defined for “where” visual networks.

Interregional RSFC changes

Significant altered connectivities among the three groups included right postcentral gyrus-right fusiform, left postcentral gyrus-right fusiform and right fusiform-right thalamus. The Post Hoc analysis demonstrated that all these altered connectivities were significantly increased in LMCI group (Figure2).

Discussion

In the present study, based on the RSFC and the probabilistic mapping of “where” visual cortices, abnormal RSFC was identified among several connections of “where” visual network at the late MCI stage. The involved brain regions included the bilateral poscentral gyrus, fusiform gyrus and thalamus. The postcentral gyrus is consistently active during action perception and execution, and may thus be considered as a brain region for motion perception4. Besides, its increased activation in MCI was consistently found in Agosta F’s study5, thus may corroborate our findings. Finally, in line with previous studies6, increased correlation between thalamus and fusiform gyrus was found in AD patients, and correlated with cognitive decline. We speculated that the elevated RSFCs in late MCI patients may imply the disruption of “where” visual network in MCI patients.

Conclusion

In this study, we investigated the “where” visual network changes in early and late MCI patients from the aspect of interregional connectivity. The findings indicated that the alternation of the “where” visual networks developed in late MCI stage, and confirmed our hypothesis. These findings could extend the current knowledge on the pattern of visual perceptual impairment in MCI patients, and could be helpful for understanding the neuroanatomical basis of their clinical dysfunctions.

Acknowledgements

The work described in this paper was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 14113214), a grant from The Science, Technology and Innovation Commission of Shenzhen Municipality (Project No. CXZZ20140606164105361), and the direct grant at CUHK (Project No.: 4054229).

Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

References

1 Rizzo M, Anderson SW, Dawson J, et al, Vision and cognition in Alzheimer's disease. Neuropsychologia 2000;38(8):1157-1169.

2 Silveri MC, Leggio MG, Influence of disorders of visual perception in word-to-picture matching tasks in patients with Alzheimer's disease. Brain Lang. 1996;54(2):326-334.

3 Cronin-Golomb Corkin A, Growdon JH, Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci. 1995;72(3):168-176.

4 Kalenine S, Buxbaum LJ, Coslett HB, Critical brain regions for action recognition: lesion symptom mapping in left hemisphere stroke. Brain 2010;133 (11) 3269-3280.

5 Agosta F, Rocca MA, Pagani E, et al, Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp. 2010;31(4):515-525.

6 Zhou B, Liu Y, Zhang Z, et al. Impaired functional connectivity of the thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state fMRI study. Curr Alzheimer Res. 2013;10 (7):754-766.

Figures

The ALE map of “where” vision.

Inter-group comparisons of the resting-state functional connectivity (RSFC) among the normal control (CN), early mild cognitive impairment (EMCI), late MCI (LMCI). Three significantly altered (p<0.001) RSFCs of the (A) R. postcentral gyrus - R. fusiform, (B) L. postcentral gyrus -R. fusiform, and (C) R. fusiform - R. thalamus are illustrated. The group with significant RSFC difference according to Post Hoc analyses (with a statistical threshold of 0.05) is marked by *. (R: right; L: left)



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1269